TECTA Εnteric-coated tablets Ref.[49691] Active ingredients: Pantoprazole

Source: Health Products and Food Branch (CA)  Revision Year: 2020 

Indications and clinical use

TECTA (pantoprazole magnesium) is indicated for the treatment of conditions where a reduction of gastric acid secretion is required, such as the following:

  • Duodenal ulcer
  • Gastric ulcer
  • Reflux esophagitis
  • Symptomatic gastro-esophageal reflux disease (such as, acid regurgitation and heartburn).
  • Helicobacter pylori associated duodenal ulcer Pantoprazole, in combination with clarithromycin and either amoxicillin or metronidazole, is indicated for the treatment of patients with an active duodenal ulcer who are H. pylori positive. Clinical trials using combinations of pantoprazole with appropriate antibiotics have indicated that such combinations are successful in eradicating H. pylori

Pediatrics

The safety and effectiveness of pantoprazole in children have not yet been established.

Geriatrics (>65 years of age)

No dosage adjustment is recommended based on age. The daily dose used in elderly patients, as a rule, should not exceed the recommended dosage regimens. See PHARMACOLOGY.

Dosage and administration

Recommended Dose and Dosage Adjustment

DUODENAL ULCER

The recommended adult dose of TECTA (pantoprazole magnesium) for the oral treatment of duodenal ulcer is 40 mg given once daily in the morning. Healing usually occurs within 2 weeks. For patients not healed after this initial course of therapy, an additional course of 2 weeks is recommended.

GASTRIC ULCER

The recommended adult oral dose of TECTA (pantoprazole magnesium) for the oral treatment of gastric ulcer is 40 mg given once daily in the morning. Healing usually occurs within 4 weeks. For patients not healed after this initial course of therapy, an additional course of 4 weeks is recommended.

HELICOBACTER PYLORI ASSOCIATED DUODENAL ULCER

Pantoprazole/Clarithromycin/Metronidazole Triple Combination Therapy: The recommended dose for H. pylori eradication is treatment for seven days with TECTA (pantoprazole magnesium) 40 mg together with clarithromycin 500 mg and metronidazole 500 mg, all twice daily.

Pantoprazole/Clarithromycin/Amoxicillin Triple Combination Therapy: The recommended dose for H. pylori eradication is treatment for seven days with TECTA (pantoprazole magnesium) 40 mg together with clarithromycin 500 mg and amoxicillin 1000 mg, all twice daily.

SYMPTOMATIC GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD)

The recommended adult oral dose for the treatment of symptoms of GERD, including heartburn and regurgitation, is TECTA (pantoprazole magnesium) 40 mg once daily for up to 4 weeks. If significant symptom relief is not obtained in 4 weeks, further investigation is required.

REFLUX ESOPHAGITIS

The recommended adult oral dose of TECTA (pantoprazole magnesium) is 40 mg, given once daily in the morning. In most patients, healing usually occurs within 4 weeks. For patients not healed after this initial course of therapy, an additional 4 weeks of treatment is recommended. Patients with healed gastroesophageal reflux disease, who require greater than usual maintenance doses of PPIs to avoid recurrence of reflux esophagitis, may consider 40 mg TECTA once daily in the morning.

Patients should use the lowest dose and shortest duration of PPI therapy appropriate to the condition being treated.

Missed Dose

If a dose is forgotten, the missed dose should be taken as soon as possible unless it is close to the next scheduled dose. Two doses should never be taken at one time to make up for a missed dose; patients should just return to the regular schedule.

Administration

TECTA (pantoprazole magnesium) is formulated as an enteric-coated tablet. A whole tablet should not be chewed or crushed, and should be swallowed with fluid in the morning either before, during, or after breakfast.

Reconstitution

Not Applicable.

Overdosage

For management of a suspected drug overdose, consult your regional Poison Control Centre.

Some reports of overdosage with pantoprazole have been received. No consistent symptom profile was observed after ingestion of high doses of pantoprazole. Daily doses of up to 272 mg pantoprazole sodium i.v. and single doses of up to 240 mg i.v. administered over 2 minutes, have been administered and were well tolerated.

As pantoprazole is extensively protein bound, it is not readily dialyzable. In the case of overdosage with clinical signs of intoxication, apart from symptomatic and supportive treatment, no specific therapeutic recommendations can be made.

Storage and stability

Store at 15°C to 30°C in the recommended packaging.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.